Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-08-15 16:24 Tx date 2019-08-13 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-164,386.02
-19,974 vol $8.23 each |
99,000 | |
Filed 2019-06-27 18:57 Tx date 2019-06-25 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+25,000 vol $2.31 each |
118,974 | |
Filed 2018-06-20 Tx date 2018-06-19 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,000
+25,000 vol $3.68 each |
93,974 | |
Filed 2018-06-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
Filed 2018-06-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
68,974 | ||
Filed 2017-08-28 Tx date 2017-08-25 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,615
+10,000 vol $2.26 each |
25,000 | |
Filed 2017-08-18 Tx date 2017-08-14 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,600
+17,500 vol $3.92 each |
68,974 | |
Filed 2016-08-15 Tx date 2016-08-11 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$53,900
+17,500 vol $3.08 each |
51,474 | |
Filed 2016-08-15 Tx date 2014-06-16 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-08-15 Tx date 2016-08-11 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,599
+15,000 vol $3.17 each |
15,000 | |
Filed 2015-07-14 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,640
+4,000 vol $11.66 each |
33,974 | |
Filed 2015-06-26 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,600
+10,000 vol $11.66 each |
29,974 | |
Filed 2015-05-15 Tx date 2015-05-14 |
$COM
Cardiome Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-82,513.98
-10,026 vol $8.23 each |
19,974 |